Toxicity, genotoxicity, and carcinogenicity of 2-methylfuran in a 90-day comprehensive toxicity study in gpt delta rats.

Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
PMID:

Abstract

2-Methylfuran (2-MF) exists naturally in foods and is used as a flavoring agent. Furan, the core structure of 2-MF, possesses hepatocarcinogenicity in rodents. Accumulation of toxicological information on furan derivatives is needed to elucidate their carcinogenic mode of action. In the current study, we examined the comprehensive toxicological studies of 2-MF using gpt delta rats. 2-MF was intragastrically administered to groups of 10 male and 10 female Sprague-Dawley gpt delta rats at a dose of 0, 1.2, 6, or 30 mg/kg/day for 13 weeks. Effects of 2-MF on the hepatobiliary system including an increase in serum alkaline phosphatase were observed in the 6 and 30 mg/kg groups, and cholangiofibrosis was found in the 30 mg/kg group. The no observed adverse effect level was set at 1.2 mg/kg/day for both sexes and 1.14 mg/kg/day was determined as the benchmark dose low. The acceptable daily intake was calculated to be 11.4 μg/kg/day. Increases in the number and areas of glutathione S-transferase placental form-positive foci in the 30 mg/kg group were apparent, suggesting the hepatocarcinogenicity of 2-MF in rats. By contrast, the lack of increase in in vivo mutagenicity in the liver implied that 2-MF hepatocarcinogenesis may not involve genotoxic mechanisms.

Authors

  • Ken Kuroda
    Division of Pathology, National Institute of Health Sciences, Kanagawa, Japan.
  • Yuji Ishii
    Division of Pathology, National Institute of Health Sciences, Kanagawa, Japan.
  • Shinji Takasu
    Division of Pathology, National Institute of Health Sciences, Kanagawa, Japan.
  • Kohei Matsushita
    Department of Gastrointestinal and Pediatric Surgery, Mie University School of Medicine, Tsu, Japan.
  • Aki Kijima
    Division of Pathology, National Institute of Health Sciences, Kanagawa, Japan.
  • Takehiko Nohmi
    Division of Pathology, National Institute of Health Sciences, Kanagawa, Japan.
  • Takashi Umemura
    Division of Pathology, National Institute of Health Sciences, Kanagawa, Japan; Yamazaki University of Animal Health, Technology, Tokyo, Japan. Electronic address: t_umemura@yamazaki.ac.jp.